参考文献/References:
[1] 李正兴,王培民,赵凌睿.中医贴敷疗法治疗膝骨性关节炎的研究进展[J].中国中医骨伤科杂志,2015,23(4):71-74.
[2] 姚志城,彭力平,林松青,等.中药外治法治疗膝骨性关节炎的最新研究进展[J].中国中医骨伤科杂志,2011,19(6):70-72.
[3] 关慧龙.非甾体类抗炎药相关上消化道出血的临床特点研究[J].中国医药指南,2015(36):171-172.
[4] 刘志清.非甾体类抗炎药致上消化道溃疡出血的临床分析[J].现代医药卫生,2015,31(10):1543-1544.
[5] Lee AS,Ellman MB,Yan D,et al.A current review of molecular mechanisms regarding osteoarthritis and pain[J].Gene,2013,527(2):440-447.
[6] Hunter DJ,Guermazi A,Roemer F,et al.Structural correlates of pain in joints with osteoarthritis[J].Osteoarthritis Cartilage,2013,21(9):1170-1178.
[7] 牛俊飞,郝悦,姚大卫,等.神经病理性疼痛的药物治疗及研究进展[J].重庆医学,2015(36):5170-5173.
[8] 刘先国,庞瑞萍,周利君,等.感觉神经损伤,还是运动神经损伤引起神经病理性疼痛[J].中国疼痛医学杂志,2015,21(3):161-169.
[9] Habib AM,Wood JN,Cox JJ.Sodium channels and pain[J].Handb Exp Pharmacol,2015,227:39-56.
[10] 朱婵,杨妞妞,唐敏,等.痛觉相关钠离子通道研究进展[J].现代生物医学进展,2014,14(36):7178-7180.
[11] 孟祥雪,赵明沂,张景海.电压门控钠离子通道与疼痛[J].沈阳药科大学学报,2011,28(8):658-662.
[12] Camargos TS,Bosmans F,Rego SC,et al.The scorpion toxin tf2 from tityus fasciolatus promotes Nav1.3 Opening[J].PLoS ONE,2015,10(6):e128578.
[13] Tan AM,Samad OA,Dib-Hajj SD,et al.Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia[J].Mol Med,2015,21:544-552.
[14] He XH,Zang Y,Chen X,et al.TNF-alpha contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury[J].Pain,2010,151(2):266-279.
[15] King GF,Vetter I.No gain,no pain:Nav1.7 as an analgesic target[J].ACS Chem Neurosci,2014,5(9):749-751.
[16] Doppler K,Sommer C.Neuropathic pain associated with Nav1.7 mutations:clinical picture and treatment[J].Nervenarzt,2013,84(12):1428-1435.
[17] Sun S,Cohen CJ,Dehnhardt CM.Inhibitors of voltage-gated sodium channel Nav1.7:patent applications since 2010[J].Pharm Pat Anal,2014,3(5):509-521.
[18] Minett MS,Pereira V,Sikandar S,et al.Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7[J].Nat Commun,2015,6:8967.
[19] Sadamasu A,Sakuma Y,Suzuki M,et al.Upregulation of NaV1.7 in dorsal root ganglia after intervertebral disc injury in rats[J].Spine,2014,39(7):E421-E426.
[20] 梁晓南,俞纲,郑志兵,等.钠通道Nav1.7与疼痛关系的研究进展[J].中国药理学与毒理学杂志,2015,29(2):297-301.
[21] Han C,Huang J,Waxman SG.Sodium channel Nav1.8:Emerging links to human disease[J].Neurology,2016,86(5):473-483.
[22] Yang F,Sun W,Yang Y,et al.SDF1-CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons:involvement of ERK-dependent Nav1.8 up-regulation[J].J Neuroinflammation,2015,12(1):219.
[23] 季晓燕,赵璇,程志军,等.骨癌痛大鼠钠通道Nav1.8的表达与行为学变化[J].上海交通大学学报:医学版,2015,35(4):511-515.
[24] Dib-Hajj SD,Black JA,Waxman SG.NaV1.9:a sodium channel linked to human pain[J].Nat Rev Neurosci,2015,16(9):511-519.
[25] Ostman JA,Nassar MA,Wood JN,et al.GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9[J].J Physiol,2008,586(4):1077-1087.
[26] Brackenbury WJ,Isom LL.Na+ channel β subunits:overachievers of the ion channel family[J].Frontiers in Pharmacology,2011,2:53.
[27] Rahman W,Dickenson AH.Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain[J].Neurosci Lett:A,2013,557(6):19-26.
[28] Eijkelkamp N,Linley JE,Baker MD,et al.Neurological perspectives on voltage-gated sodium channels[J].Brain,2012,135(Pt 9):2585-2612.
[29] Namadurai S,Yereddi NR,Cusdin FS,et al.A new look at sodium channel βsubunits[J].Open Biol,2015,5(1):140192.
[30] Munasinghe NR,Christie MJ.Conotoxins that could provide analgesia through voltage gated sodium channel Inhibition[J].Toxins(Basel),2015,7(12):5386-5407.
[31] Brouwer BA,Merkies IS,Gerrits MM,et al.Painful neuropathies:the emerging role of sodium channelopathies[J].J Peripher Nerv Syst,2014,19(2):53-65.
[32] 王红艳,勾萌,肖蓉,等.钠离子通道疾病及其抑制剂生物学功能研究进展[J].生物工程学报,2014,30(6):875-890.